The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer. Zhang W, Cao H, Yang J, Zhao J, et al. BMC Cancer 2022;22:636.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Cao H, Yang J, Zhao J, et al. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer. BMC Cancer 2022;22:636.
PMID: 35681118